Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Clinical trial NCT00003616 · COMPLETED
Trial details
- NCT number
- NCT00003616
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-10-22
- Primary completion
- 2002-05-17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.